Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
1,881
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study

Paul Kambale-Kombia Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the CongoCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7196-8217
ORCID Icon,
Roland Marini Djang’eing’ab Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo;c Department of Pharmaceutical Sciences, Laboratory of Analytical Chemistry, Faculty of Medicine, University of Liège, Liège, Belgium
,
Jean-Pierre Alworong’a Oparad Department of Pediatrics, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
,
Jean-Marc Minone Department of Laboratory Medicine, Transfusion and Thrombosis-Haemostasis Unit, Centre Hospitalier Régional de la Citadelle, Liège, Belgium
,
Camille Atoba Bokelea Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
,
Vincent Boursf Department of Human Genetics, CHU of Liège, University of Liège, Liège, Belgium
,
Marie-Agnès Azeradg Department of Haematology, CHU of Liège at Site CHR Citadelle, Liège, Belgium
,
Serge Tonen-Wolyeca Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the CongoORCID Iconhttps://orcid.org/0000-0002-7734-7729
ORCID Icon,
Charles Kayembe Tshilumbaa Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
&
Salomon Batina-Agasaa Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
 show all
Pages 590-595 | Published online: 26 May 2022

References

  • Tsaras G, Owusu-Ansah A, Boateng FO, et al. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009;122(6):507–512.
  • Xu JZ, Thein SL. The carrier state for sickle cell disease is not completely harmless. Haematologica. 2019;104(6):1106–1111.
  • Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573.
  • Cappelini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64–74.
  • Fasola FA, Fowodu FO, Shokunbi WA, et al. The effect of the coinheritance of glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease. Niger Postgrad Med J. 2019;26(2):118–122.
  • Lewis RA, Kay RW, Hathorn M. Sickle cell disease and glucose-6-phosphate dehydrogase. Acta Haemat. 1966;36:399–411.
  • Gibbs WN, Wardle J, Serjeant GR. Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Jamaica. Br J Haematol. 1980;45(1):73–80.
  • Diop S, Thiam D, Sene A, et al. L’Association drépanocytose-déficit en G-6-PD: prévalence et influence sur le profil évolutif. Médecine D'Afrique Noire. 2000;47(7):322–326.
  • Antwi-Baffour S, Adjei JK, Forson PO, et al. Comorbidity of glucose-6-phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices. Anemia. 2019;2019:3179173.
  • Karafin MS, Fu X, D'Alessandro A, et al. The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease. Curr Opin Hematol. 2018;25(6):494–499.
  • Lu YW, Chen TC. Use of trimethoprim-sulfamethoxazole in a patient with G-6-PD deficiency for treating pneumocystis jirovecii pneumonia without haemolysis: case report and literature review. J Clin Pharm Ther. 2020;45(6):1483–1485.
  • Poirot E, Vittinghoff E, Ishengoma D, et al. Risks of hemolysis in glucose-6-phosphate dehydrogenase deficient Infants exposed to chlorproguanil-dapsone, mefloquine and sulfadoxine-pyrimethamine as part of intermittent presumptive treatment of malaria in Infants. PLoS One. 2015 Nov 23;10(11):e0142414.
  • Sansone S, Rottensteiner J, Stocker J, et al. Ciprofloxacin-induced acute haemolytic anaemia in a patient with glucose-6-phosphate dehydrogenase Mediterranean deficiency: a case report. Ann Hematol. 2010;89(9):935–937.
  • Howes RE, Piel FB, Patil AP, et al. G-6-PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9(11):e1001339.
  • Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med. 2010;20(1):62–65.
  • Roper D, Layton M, Rees D, et al. Laboratory diagnosis of G-6-PD deficiency. A British society for haematology guideline. Br J Haematol. 2020;189(1):24–38.
  • Steele C, Sinski A, Asibey J, et al. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test. Am J Hematol. 2019;94(1):39–45.
  • Mbanefo EC, Ahmed AM, Titouna A, et al. Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis. Sci Rep. 2017;7:45963.
  • Antwi-Baffour S, Adjei JK, Forson PO, et al. Comorbidity of glucose-6-phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices. Anemia. 2019;2019:3179173.
  • Bouanga JC, Mouélé R, Préhu C, et al. Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo. Hum Hered. 1998;48(4):192–197.
  • Sagiv E, Fasano RM, Luban NLC, et al. Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease. Am J Hematol. 2018;93(5):630–634.
  • Benkerrou M, Alberti C, Couque N, et al. Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study. Br J Haematol. 2013;163(5):646–654.
  • Osho PO, Ojo MD, Osho ES, et al. Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression: a case report. International Journal of Genetics and Genomics. 2020;8(3):102–105.
  • Igwilo HN, Salawu L, Adeoye Adedeji T. The impact of glucose-6-phosphate dehydrogenase deficiency on the frequency of vasoocclusive crisis in patients with sickle cell anemia. Plasmatology. 2021;15:1–10.
  • Simpore J, Ilboudo D, Damintoti K, et al. Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso. Pak J Biol Sci. 2007;10(3):409–414.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.